ArthroCare Corp. (NASDAQ: ARTC) announced today the publication of an important clinical trial demonstrating that patients treated with ArthroCare's Plasma ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE